Work

Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma

Year: 2013

Type: article

Study design: Observational Study

Source: Journal of Clinical Pathology

DOI: 10.1136/jclinpath-2013-201619

Authors: E Frei, C Visco, Z Y Xu-Monette, S Dirnhofer, K Dybkær, A Orazi, G Bhagat, E D Hsi, J H van Krieken, M Ponzoni, R S Go, M A Piris, M B Møller, K H Young, A Tzankov

Institutions: University Hospital of Basel, Ospedale San Bortolo, The University of Texas MD Anderson Cancer Center, Aalborg University Hospital, Aarhus University Hospital, Cornell University, Weill Cornell Medicine, NewYork–Presbyterian Hospital, Columbia University Irving Medical Center, Cleveland Clinic, Radboud University Medical Center, IRCCS Ospedale San Raffaele, Gundersen Health System, Gundersen Lutheran Hospital, Marqués de Valdecilla University Hospital, Odense University Hospital

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2131370499

FWCI: 2.741

Cites: 46

Cited by: 29

Related to: 10